QR Kod

Development of a comprehensive cardiovascular disease genetic risk assessment test

Purpose: Despite monogenic and polygenic contributions to cardiovascular disease (CVD), genetic testing is not widely adopted, and current tests are limited by the breadth of surveyed conditions and variant interpretation burden. To address these limitations, a comprehensive clinical genome CVD test...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Laura M. Amendola, Alison J. Coffey, Josh Lowry, James Avecilla, Alka Malhotra, Aditi Chawla, Stetson Thacker, Julie P. Taylor, Revathi Rajkumar, Carolyn M. Brown, Katie Golden-Grant, Rueben Hejja, Tasha Kalista, Jennifer A. Lee, Phillip Medrano, Becky Milewski, Felipe Mullen, Andrew Walker, Adriana Huertas-Vazquez, Mauro Longoni, Keisha Robinson, Denise L. Perry, Damon Hostin, Subramanian S. Ajay, Akanchha Kesari, Samuel P. Strom, Elliott Margulies, John Belmont, David E. Lanfear, Ryan J. Taft
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2026-01-01
Seri Bilgileri:Genetics in Medicine Open
Konular:
Cardiovascular disease
Genome sequencing
Monogenic disease
Pharmacogenomics
Polygenic risk
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2949774425015213
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller